Bimekizumab
ucb biopharma
['bimekizumab', 'hidradenitis', 'derm', ' hs ']
first results from bimekizumab (anti il-17f drug) study for the treatment of #hidradenitissuppurativa new: endpoint hiscr 75 achieved at week 16 #dermatology #aad2023 
Dermatovenerologist, University Hospital Center Zagreb Rebro, Harvard Kennedy School MPP graduate, Zg-St